No live calls today · full consensus board · no graded calls yet
Price (daily close, 2026-10-23)
Trailing returns (daily closes)
Recent news
| 2026-10-24 | Immunovant CTO Jay Stout sells $75,099 in shares · investing_com |
| 2026-10-21 | Immunovant to Report Financial Results for the Second Fiscal Quarter Ended September 30, 2026, and Provide Business Update on Monday, November 9, 2026 · globe_newswire |
| 2026-10-20 | Immunovant: Batoclimab 2.0 Bull Case Flawed By Mixed Data, Competitive Threats · seeking_alpha |
How grading works: every call is locked before the open and scored on the session's open→close move — see the methodology.
Open Fortivio.AI →Model-generated predictions with a live graded record — not investment advice. 模型生成的预测，非投资建议。